Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.
MICHIGAN CITY, Ind.–(BUSINESS WIRE)–Horizon Bancorp (NASDAQ: HBNC), an Indiana headquartered community bank holding company, announced today that it entered into a definitive agreement to acquire Heartland Bancshares, Inc. (OTCBB: HRTB) and its wholly-owned subsidiary, Heartland Community Bank, based in Franklin, Indiana. Under the terms of the merger agreement, Horizon has agreed to issue 0.54 shares (subject to adjustment) of its common stock for each share of Heartland common stock outstand
Here is the original post:
Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.
Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.
MICHIGAN CITY, Ind.–(BUSINESS WIRE)–Horizon Bancorp (NASDAQ: HBNC), an Indiana headquartered community bank holding company, announced today that it entered into a definitive agreement to acquire Heartland Bancshares, Inc. (OTCBB: HRTB) and its wholly-owned subsidiary, Heartland Community Bank, based in Franklin, Indiana. Under the terms of the merger agreement, Horizon has agreed to issue 0.54 shares (subject to adjustment) of its common stock for each share of Heartland common stock outstand
More here:
Horizon Bancorp Announces Definitive Agreement to Acquire Indiana-Based Heartland Bancshares, Inc.
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
SCHAUMBURG, Ill.–(BUSINESS WIRE)–APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States.
See the rest here:
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
SCHAUMBURG, Ill.–(BUSINESS WIRE)–APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States.
Read the original:
APP Pharmaceuticals Announces Launch of Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP
Rubicon Will Report Fourth Quarter Results on February 23, 2012
BENSENVILLE, Ill.–(BUSINESS WIRE)–Earnings Call Date Announcement for RBCN
Here is the original post:
Rubicon Will Report Fourth Quarter Results on February 23, 2012
Rubicon Will Report Fourth Quarter Results on February 23, 2012
BENSENVILLE, Ill.–(BUSINESS WIRE)–Earnings Call Date Announcement for RBCN
Read more here:
Rubicon Will Report Fourth Quarter Results on February 23, 2012
CF Industries Holdings, Inc. Announces Updated Start Time for Fourth Quarter and Full Year 2011 Conference Call
DEERFIELD, Ill.–(BUSINESS WIRE)–CF Industries Holdings, Inc. (NYSE: CF) today announced an update to its previously announced conference call to discuss fourth quarter and full year 2011 results. The company now plans to host the conference call to discuss these results at 9:00 a.m. ET on Thursday, February 16, 2012. The results will be released after the market closes on Wednesday, February 15, 2012. Investors can access the call by dialing 800-299-0148 or 617-801-9711. The passcode is 145900
CF Industries Holdings, Inc. Announces Updated Start Time for Fourth Quarter and Full Year 2011 Conference Call
DEERFIELD, Ill.–(BUSINESS WIRE)–CF Industries Holdings, Inc. (NYSE: CF) today announced an update to its previously announced conference call to discuss fourth quarter and full year 2011 results. The company now plans to host the conference call to discuss these results at 9:00 a.m. ET on Thursday, February 16, 2012. The results will be released after the market closes on Wednesday, February 15, 2012. Investors can access the call by dialing 800-299-0148 or 617-801-9711. The passcode is 145900
Inland Real Estate Corporation Reports Fourth Quarter and Year 2011 Results
OAK BROOK, Ill.–(BUSINESS WIRE)–Inland Real Estate Corporation (NYSE: IRC) today announced financial and operational results for the three and twelve months ended December 31, 2011. Key Points Funds From Operations (FFO) per common share was $0.21 and FFO adjusted for impairment of non-depreciable real estate and other non-cash adjustments, net of taxes, per common share was $0.22 for the fourth quarter of 2011, compared to FFO and FFO adjusted per share of $0.21 for the fourth quarter of 2010
More:
Inland Real Estate Corporation Reports Fourth Quarter and Year 2011 Results
BZRK The Game for iOS & Android Platforms Invites Players to Experience the Highly Anticipated Interactive Franchise
CHICAGO–(BUSINESS WIRE)–BZRK The Game to Expand on The Shadow Gang and Newest Michael Grant Thriller
Here is the original post:
BZRK The Game for iOS & Android Platforms Invites Players to Experience the Highly Anticipated Interactive Franchise
